Portal de Periódicos da CAPES

Do novel drugs for diabetes help in COVID ‐19? Another brick in the wall?

2020; Wiley; Volume: 12; Issue: 9 Linguagem: Inglês

10.1111/1753-0407.13050

1753-0393

Alicja Krejner‐Bienias, Katarzyna Grzela, Tomasz Grzela,

Diabetes Management and Research

Journal of DiabetesVolume 12, Issue 9 p. 703-704 LETTER TO THE EDITOR Do novel drugs for diabetes help in COVID-19? Another brick in the wall? Alicja Krejner-Bienias, Alicja Krejner-Bienias Department of Histology and Embryology, Medical University of Warsaw, PolandSearch for more papers by this authorKatarzyna Grzela, Katarzyna Grzela Department of Pediatric Pulmonology and Allergology, Medical University of Warsaw, PolandSearch for more papers by this authorTomasz Grzela, Corresponding Author Tomasz Grzela [email protected] orcid.org/0000-0001-8519-4868 Department of Histology and Embryology, Medical University of Warsaw, Poland Correspondence Tomasz Grzela, Biostructure Research Centre, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland. Email: [email protected]Search for more papers by this author Alicja Krejner-Bienias, Alicja Krejner-Bienias Department of Histology and Embryology, Medical University of Warsaw, PolandSearch for more papers by this authorKatarzyna Grzela, Katarzyna Grzela Department of Pediatric Pulmonology and Allergology, Medical University of Warsaw, PolandSearch for more papers by this authorTomasz Grzela, Corresponding Author Tomasz Grzela [email protected] orcid.org/0000-0001-8519-4868 Department of Histology and Embryology, Medical University of Warsaw, Poland Correspondence Tomasz Grzela, Biostructure Research Centre, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland. Email: [email protected]Search for more papers by this author First published: 10 May 2020 https://doi.org/10.1111/1753-0407.13050Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382: 1663-1665. https://doi.org/10.1056/NEJMc2005073. 10.1056/NEJMc2005073 PubMedWeb of Science®Google Scholar 2Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;e20200702. https://doi.org/10.1542/peds.2020-0702. 10.1542/peds.2020-0702 PubMedWeb of Science®Google Scholar 3Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020; 10: 102-108. https://doi.org/10.1016/j.jpha.2020.03.001. 10.1016/j.jpha.2020.03.001 PubMedWeb of Science®Google Scholar 4Lamers D, Famulla S, Wronkowitz N, et al. Dipeptidyl peptidase 4 is a novel Adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011; 60: 1917-1925. https://doi.org/10.2337/db10-1707. 10.2337/db10-1707 CASPubMedWeb of Science®Google Scholar 5Dudkowski C, Tsai M, Liu J, Zhao Z, Schmidt E, Xie J. The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus. Eur J Clin Pharmacol. 2017; 73: 279-288. doi.org/10.1007/s00228-016-2175-1. 10.1007/s00228-016-2175-1 CASPubMedWeb of Science®Google Scholar Citing Literature Volume12, Issue9September 2020Pages 703-704 ReferencesRelatedInformation